EMERGENT BIOSOLUTIONS INC Chart calendar Emergent Biosolutions Inc
c6060a5fb8.SW2Sgylww7bjiheTy4_WIpafyGuT4vV17o8W1J1bmkQ.eD_c8mIjm9W03yP_m9eFbezpvyzft4ZEmeZMpPki9S0kQNf7SEnzzrneIw~a30204bc99877b914a52ed3124e22aeb
Upcoming events on Emergent Biosolutions Inc
Past events on Emergent Biosolutions Inc
| 2024-05-01 17:00 | Q1 2024 Earnings Call |
| 2024-05-01 16:57 | Q1 2024 Earnings Release |
| 2024-03-06 17:00 | Q4 2023 Earnings Call |
| 2024-03-06 16:31 | Q4 2023 Earnings Release |
| 2024-01-11 12:00 | JPMorgan Healthcare Conference |
| 2023-12-07 14:15 | Singular Research Best of the Uncovered Conference |
| 2023-11-08 17:38 | Q3 2023 Earnings Release |
| 2023-11-08 17:00 | Q3 2023 Earnings Call |
| 2023-09-13 17:30 | Singular Research Autumn Equinox Conferece |
| 2023-08-08 17:00 | Q2 2023 Earnings Call |
| 2023-08-08 16:31 | Q2 2023 Earnings Release |
| 2023-05-25 09:00 | Annual General Meeting |
| 2023-05-09 17:00 | Q1 2023 Earnings Call |
| 2023-05-09 16:05 | Q1 2023 Earnings Release |
| 2023-02-27 17:00 | Q4 2022 Earnings Call |
| 2023-02-27 16:42 | Q4 2022 Earnings Release |
| 2022-11-15 | Three Part Advisors 2022 Southwest IDEAS Conference |
| 2022-11-08 17:00 | Q3 2022 Earnings Call |
| 2022-11-07 | Q3 2022 Earnings Release After hours |
| 2022-09-14 10:45 | Singular Research Autumn Equinox Compelling Values Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 106 1 104 0.18% | 1 555 1 547 0.52% | 1 793 1 746 2.65% | 1 121 1 088 2.98% | 1 049 1 047 0.19% | 1 015 |
|
EBITDA Million USD | Released Forecast Spread | 280 265 5.36% | 630 630 0.07% | 518 498 3.94% | 26,1 10,0 161% | -22,3 -0,10 -22200% | 75,0 |
|
EBIT Million USD | Released Forecast Spread | 114 124 -7.99% | 434 401 8.15% | 353 362 -2.69% | -173 -164 -5.25% | -726 -435 -66.88% | -88,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 77,4 86,2 -10.26% | 407 370 9.92% | 314 326 -3.43% | -222 -216 -2.46% | -731 -708 -3.25% | -160 |
|
Net income Million USD | Released Forecast Spread | 54,5 56,4 -3.33% | 305 300 1.65% | 231 267 -13.68% | -224 -203 -10.08% | -761 -742 -2.47% | -155 |
|
EPS USD | Released Forecast Spread | 1,04 1,07 -2.88% | 5,67 5,52 2.72% | 4,27 5,07 -15.72% | -4,47 -4,16 -7.55% | -14,9 -14,4 -3.45% | -2,99 |
| Announcement Date | 20/02/20 | 18/02/21 | 24/02/22 | 27/02/23 | 06/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 308 285 7.98% | 243 268 -9.56% | 240 266 -9.89% | 331 298 10.89% | 165 143 15.58% | 338 217 55.89% | 271 238 13.87% | 277 274 0.95% | 300 220 36.39% | 222 | 307 | 267 |
|
EBITDA Million USD | Released Forecast Spread | 36,0 28,3 27.43% | -28,8 45,8 -162.95% | -15,2 | 34,2 18,0 90% | -101 18,0 -660% | 55,9 6,60 746.97% | 19,8 24,6 -19.51% | 3,40 25,0 -86.4% | 66,9 -5,50 1316.36% | 9,50 | 28,0 | 43,0 |
|
EBIT Million USD | Released Forecast Spread | 6,40 11,5 -44.35% | -72,0 26,2 -374.81% | -42,0 -3,75 -1020% | -65,1 -56,5 -15.29% | -148 -80,6 -83.75% | 13,8 -45,5 130.33% | -242 -25,9 -834.75% | -43,8 -14,5 -202.07% | 39,8 -40,8 197.67% | -37,8 | 2,50 | -12,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,80 2,25 -268.89% | -82,8 17,4 -575.86% | -63,9 -12,7 -405.14% | -71,2 -66,0 -7.88% | -161 -89,5 -80% | -250 -60,6 -312.87% | -266 -32,6 -715.64% | -54,5 -31,0 -75.81% | 12,1 -58,5 120.68% | -56,0 | -15,3 | -30,3 |
|
Net income Million USD | Released Forecast Spread | -3,70 -5,45 32.11% | -56,4 26,5 -313.23% | -75,7 -4,00 -1792.5% | -88,0 -79,3 -10.97% | -183 -67,0 -173.34% | -261 -54,3 -381.22% | -263 -29,8 -785.38% | -49,5 -35,0 -41.43% | 9,00 -55,5 116.22% | -45,5 | -32,0 | -22,0 |
|
EPS USD | Released Forecast Spread | -0,07 -0,15 51.94% | -1,13 -0,40 -184.87% | -1,52 -0,33 -355.36% | -1,76 -1,42 -24.18% | -3,65 -1,63 -123.36% | -5,15 -0,99 -420.2% | -5,08 -0,54 -840.74% | -0,95 -0,60 -58.51% | 0,17 -1,11 115.36% | -1,05 | -0,27 | -0,56 |
| Announcement Date | 28/04/22 | 01/08/22 | 08/11/22 | 27/02/23 | 09/05/23 | 08/08/23 | 08/11/23 | 06/03/24 | 01/05/24 | - | - | - |
More events
Past sector events for Emergent Biosolutions Inc
| 2024-05-16 | J. B. CHEMICALS & PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-15 10:05 | MANKIND PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-15 01:30 | DERMAPHARM HOLDING SE: Q1 2024 Earnings Release |
| 2024-05-15 07:40 | CRESCO LABS INC.: Q1 2024 Earnings Release |
| 2024-05-15 03:03 | GRANULES INDIA LIMITED: Q4 2024 Earnings Release |
| 2024-05-14 | EISAI CO., LTD.: Q4 2023 Earnings Release |
| 2024-05-14 17:43 | LIQUIDIA CORPORATION: Q1 2024 Earnings Release |
| 2024-05-14 04:52 | BORA PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-14 01:30 | BAYER AG: Q1 2024 Earnings Release |
